We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-21.98%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
$0
Cap. Flow
-$63.6K
Cap. Flow %
-0%
Top 10 Hldgs %
13.08%
Holding
3,173
New
Increased
3
Reduced
4
Closed

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POWL icon
2226
Powell Industries
POWL
$7.6B
$4K ﹤0.01%
261
HTT
2227
High Templar Tech Ltd
HTT
$379M
$4K ﹤0.01%
1,000
QNST icon
2228
QuinStreet
QNST
$890M
$4K ﹤0.01%
301
RGA icon
2229
Reinsurance Group of America
RGA
$15.5B
$4K ﹤0.01%
28
SAFE
2230
Safehold
SAFE
$1.16B
$4K ﹤0.01%
65
SPB icon
2231
Spectrum Brands
SPB
$2.04B
$4K ﹤0.01%
77
SXC icon
2232
SunCoke Energy
SXC
$720M
$4K ﹤0.01%
891
TDC icon
2233
Teradata
TDC
$2.92B
$4K ﹤0.01%
150
TEI
2234
Templeton Emerging Markets Income Fund
TEI
$314M
$4K ﹤0.01%
500
TSLX icon
2235
Sixth Street Specialty
TSLX
$1.63B
$4K ﹤0.01%
200
UCTT
2236
Ultra Clean Holdings
UCTT
$3.73B
$4K ﹤0.01%
209
UIS icon
2237
Unisys
UIS
$209M
$4K ﹤0.01%
381
VECO icon
2238
Veeco
VECO
$3.05B
$4K ﹤0.01%
287
WOLF icon
2239
Wolfspeed
WOLF
$1.23B
$4K ﹤0.01%
107
WWD icon
2240
Woodward
WWD
$21.5B
$4K ﹤0.01%
37
ONC
2241
BeOne Medicines Ltd
ONC
$32.8B
$4K ﹤0.01%
29
NVRO
2242
DELISTED
NEVRO CORP.
NVRO
$4K ﹤0.01%
40
EGRX
2243
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$4K ﹤0.01%
76
ITCL
2244
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
$4K ﹤0.01%
512
DBD
2245
DELISTED
Diebold Nixdorf Incorporated
DBD
$4K ﹤0.01%
466
CVA
2246
DELISTED
Covanta Holding Corporation
CVA
$4K ﹤0.01%
331
LDL
2247
DELISTED
Lydall, Inc.
LDL
$4K ﹤0.01%
228
RP
2248
DELISTED
RealPage, Inc.
RP
$4K ﹤0.01%
85
MIK
2249
DELISTED
Michaels Stores, Inc
MIK
$4K ﹤0.01%
665
SINA
2250
DELISTED
Sina Corp
SINA
$4K ﹤0.01%
124

Similar funds

Glenmede Trust's Q1 2020 Portfolio in Review

As of Q1 2020, Glenmede Trust held 3,173 positions worth $21.9B, unchanged from the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Trading was light in Q1 2020: portfolio turnover was 0%. Glenmede Trust opened no new positions and made no exits, leaving the 3,173-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, unchanged from a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust added most to Interpace Biosciences, Inc. Common Stock in Q1 2020, an estimated $51.9K increase.
  • Glenmede Trust's biggest Q1 2020 reduction was Brookfield Infrastructure Partners, cutting an estimated $78.8K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q1 2020.
  • Glenmede Trust opened 0 new positions and closed 0 in Q1 2020.
  • Glenmede Trust's portfolio value was unchanged quarter-over-quarter at $21.9B.

Based on Glenmede Trust's 13F filing for Q1 2020, filed 20 May 2020.